Search

Home > JAMA Clinical Reviews > CAR T Cells and T-Cell Therapies for Cancer
Podcast: JAMA Clinical Reviews
Episode:

CAR T Cells and T-Cell Therapies for Cancer

Category: Health
Duration: 00:18:22
Publish Date: 2024-11-04 16:00:00
Description:

CAR T cells are genetically engineered to express a receptor that recognizes and kills tumor cells. CAR T-cell products are now FDA approved for 6 hematologic malignancies. Author Jennifer N. Brudno, MD, National Cancer Institute, joins JAMA Deputy Editor Mary McGrae McDermott, MD, to discuss "CAR T Cells and T-Cell Therapies for Cancer: A Translational Science Review.” Related Content:

Total Play: 0

Some more Podcasts by American Medical Association

1K+ Episodes